The Role of Endothelial Progenitor Cell in Cardiovascular Disease Risk Factors

Authors

  • Rahmawati Minhajat Department of Internal Medicine. Faculty of Medicine Hasanuddin University, Makassar, Indonesia
  • Dina Nilasari Department of Internal Medicine. Faculty of Medicine Hasanuddin University, Makassar, Indonesia
  • Syakib Bakri Department of Internal Medicine. Faculty of Medicine Hasanuddin University, Makassar, Indonesia

Abstract

Endothelial progenitor cells (EPCs) are cell derived from bone marrow and the cells circulate in peripheral blood. These cells have characteristics similar to stem cells, but their ability to proliferate and differentiate is more limited. EPC discovery has changed the old paradigm in the field of vascular biology and it brings huge implications in medicine as EPCs can mediate the processes of vasculogenesis and maintain the vascular integrity. Increasing amount of EPC in the circulation is important since it has positive correlation with reendothelialization and neovascularization and they are closely linked to cardiovascular health. Thus, EPC could potentially be used for treatment of disease caused by endothelial dysfunction.Key words: endothelial progenitor cell, endothelial dysfunction, vasculogenesis, reendothelialization.

Downloads

How to Cite

Minhajat, R., Nilasari, D., & Bakri, S. (2016). The Role of Endothelial Progenitor Cell in Cardiovascular Disease Risk Factors. Acta Medica Indonesiana, 47(4). Retrieved from https://www.actamedindones.org/index.php/ijim/article/view/27

Issue

Section

REVIEW ARTICLE